Received Jul 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X019862 | — |
Confirmed no symptomatic adverse events; Inbound call from nurse calling to report administration of expired GARDASIL-9 to a patient on 18-MAR-2025. Caller states that they discovered that the dose was administered expired after the patient came in recently for the next dose. Confirmed no; This spontaneous report was received from a nurse and refers to a 22-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-Mar-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (lot #X019862, expiration date: 14-Feb-2025) (0.5 ml / once), for prophylaxis, administration of expired vaccine (expired product administered). The nurse reported that it was discovered that the dose was administered expired after the patient came in recently for the next dose. Confirmed no symptomatic adverse events (no adverse event).